Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep;11(9):1739-1741.
doi: 10.21037/tlcr-22-513.

Complex glandular pattern as an independent predictor of survival probability in lung adenocarcinoma

Affiliations
Editorial

Complex glandular pattern as an independent predictor of survival probability in lung adenocarcinoma

Per Hydbring. Transl Lung Cancer Res. 2022 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-22-513/coif). The author has no conflicts of interest to declare.

Comment on

References

    1. Moreira AL, Ocampo PSS, Xia Y, et al. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee. J Thorac Oncol 2020;15:1599-610. 10.1016/j.jtho.2020.06.001 - DOI - PMC - PubMed
    1. Moreira AL, Joubert P, Downey RJ, et al. Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma. Hum Pathol 2014;45:213-20. 10.1016/j.humpath.2013.10.011 - DOI - PubMed
    1. Bai J, Deng C, Zheng Q, et al. Comprehensive analysis of mutational profile and prognostic significance of complex glandular pattern in lung adenocarcinoma. Transl Lung Cancer Res 2022;11:1337-47. 10.21037/tlcr-22-127 - DOI - PMC - PubMed
    1. Warth A, Muley T, Kossakowski C, et al. Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma. J Thorac Oncol 2015;10:638-44. 10.1097/JTO.0000000000000490 - DOI - PubMed
    1. Jackman DM, Yeap BY, Sequist LV, et al. Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib. Clin Cancer Res 2006;12:3908-14. 10.1158/1078-0432.CCR-06-0462 - DOI - PubMed